MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...

MEI Pharma ( (MEIP)) has issued an update. On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

MEI Pharma has taken a major step, becoming the first publicly traded firm on a national exchange to include Litecoin (LTC) as a major treasury reserve asset. Starting with a $100 million private ...

Key Points MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie ...

Charlie Lee, the co-founder of litecoin, is investing $100mn into MEI Pharma in order for the cancer care company to buy the ...

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

Some crypto projects are fading into the background. Others are quietly gathering steam. And then there’s DeSoc, the kind of ...

Extending the BTC treasury plans to smaller altcoins has been described as "hugely speculative" and a "flash in the pan" ...

Litecoin price prediction chatter has returned with force after LTC surged 23% in a single day, hitting $119, its highest ...